Episode Summary
Executive Summary: The episode examines methamphetamine’s history, focusing on how Nazi Germany’s Pervitin was developed, marketed, and used to fuel military endurance during World War II, while also noting Allied stimulant use. It traces the drug’s scientific origins, Nazi adoption, battlefield impact, side effects, and postwar legacy in medicine, warfare, and drug control.
Main Topics: Origins of methamphetamine and early stimulant chemistry (Priority: 5/5): The hosts trace the development of ephedrine and methamphetamine from Japanese and European chemistry, showing that Pervitin’s creation built on earlier scientific work rather than a single inventor. Pervitin’s commercialization in Nazi Germany (Priority: 5/5): Temmler’s synthetic methamphetamine was aggressively marketed as a life-enhancing stimulant, helping normalize broad civilian use despite Nazi ideology that publicly condemned weakness and drug abuse. Military testing and Wehrmacht adoption (Priority: 5/5): Nazi military researchers tested Pervitin for fatigue and alertness, then spread its use through the Wehrmacht, especially in early blitzkrieg campaigns where endurance and speed were prized. Health consequences and addiction (Priority: 5/5): The episode details the drug’s adverse effects—insomnia, psychosis, heart problems, paranoia, and dependency—emphasizing that short-term performance gains came with severe physical and mental costs. Stimulant use among the Allies and Japan (Priority: 4/5): The discussion broadens beyond Germany to note that Allied forces also used stimulants such as Benzedrine, while Japan developed a similar drug for pilots, showing stimulant warfare was multinational. Postwar legacy and drug regulation (Priority: 4/5): Pervitin and amphetamine’s long afterlife in civilian medicine and military use is covered, including their eventual classification as controlled substances and the ongoing problem of methamphetamine abuse.
Key Arguments: Pervitin was not an ideological contradiction to Nazi policy so much as a tool that was re-framed as enhancing strength, productivity, and racial fitness. The German military’s use of methamphetamine contributed to the tempo and reach of blitzkrieg by suppressing fatigue and hunger in troops. Claims that meth was uniquely or universally decisive for German victory are overstated; use was significant but uneven, and historians dispute the scale. Allied and Japanese forces also used stimulants, so the history of wartime drug use is broader than a Nazi-only story. The drug’s short-term military value was offset by long-term harm: addiction, psychosis, cardiovascular strain, and poor judgment. Postwar medical and military institutions continued using amphetamines because performance benefits were still valued despite known risks.
Data Points: Translation publication year of Blitzed: 2017 - English-language edition of Norman Ohler’s book on drug use in Nazi Germany Original publication year of Der Total Gausch: 2015 - German publication that sparked renewed attention to Nazi stimulant use Temmler daily production of Pervitin: More than 800,000 tablets per day - Reported manufacturing output in 1940 to meet demand Pervitin tablet package size: 30 tablets - Standard small metal cylinder packaging Methamphetamine content per tablet: 0.003 milligrams - As stated in the transcript’s description of the packaging Years Pervitin remained on the market: Until 1988 - The drug continued in some form long after World War II Year amphetamine became a controlled substance in the U.S.: 1970 - After the Controlled Substances Act was passed Year Benzedrine became prescription-only in the U.S.: 1959 - Part of postwar stimulant regulation Year ephedrine was manufactured by Dai Nippon Pharmaceutical Company: 1885 - Based on Nagai’s work on ephedrine extraction Year Lazar Edeleanu synthesized amphetamine: 1887 - Early European synthesis in Berlin Year Gordon Alles patented amphetamine sulfate: 1932 - Key step before Benzedrine marketing Year Pervitin entered the market: 1937 - Temmler patented and launched the product under the brand name Pervitin Year of official Wehrmacht Pervitin issue to 3rd Tank Division: 1938 - During the occupation of Sudetenland Year of invasion of Poland: 1939 - A major early combat use of Pervitin by German forces Year of Ardennes/French campaign referenced: 1940 - Pervitin-supported rapid advance through difficult terrain Year Pervitin moved to prescription-only in Germany: 1941 - Due to civilian complaints and side effects Nazi euthanasia program deaths referenced: More than 70,000 people - A reminder that Reich health officials were deeply complicit in atrocities
Pivotal Quotes: "Anyone who thinks they can eliminate fatigue with purvitin can be certain that its boosting effect will one day abruptly cease." — Leonardo Conti: Warning to the Nazi Party’s medical association about the limits and risks of stimulant use "a militarily valuable substance" — Otto Friedrich Ranke: His assessment after testing Pervitin on military medical officers and comparing it with caffeine, Benzedrine, and placebo "only from time to time" — Pervitin label warning: The product label’s caution about limited use, despite broad civilian and military adoption
Implications: The episode shows how performance-enhancing drugs can be normalized by institutions that prize endurance and productivity. It also warns that wartime stimulant use has lasting medical, ethical, and regulatory consequences that still matter today.